Toward optimal external-beam fractionation for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 2, 2000, Pages 315-316

  Brenner, David J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; EDITORIAL; GASTROINTESTINAL DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION STERILIZATION;

CELL CYCLE; DOSE FRACTIONATION; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIATION INJURIES;

EID: 0033827964     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00591-5     Document Type: Editorial

References (12)

1. Pollack A., Zagars G.K., Rosen I.I. Prostate cancer treatment with radiotherapy Maturing methods that minimize morbidity . Semin Oncol. 26:1999;150-161.
2. Yu Y., Anderson L.L., Li Z., et al. Permanent prostate seed implant brachytherapy Report of the American Association of Physicists in Medicine Task Group No. 64 . Med Phys. 26:1999;2054-2076.
3. Forman J.D., Duclos M., Shamsa F., et al. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer Results of a dose escalation study . Int J Radiat Oncol Biol Phys. 34:1996;655-662.
4. Mohan D.S., Kupelian P.A., Willoughby T.R. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int J Radiat Oncol Biol Phys. 46:2000;575-580.
5. Haustermans K.M., Hofland I., Van Poppel H., et al. Cell kinetic measurements in prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;1067-1070.
6. Thames H.D. Jr, Withers H.R., Peters L.J., et al. Changes in early and late radiation responses with altered dose fractionation Implications for dose-survival relationships . Int J Radiat Oncol Biol Phys. 8:1982;219-226.
7. Scrivner D.L., Meyer J.S., Rujanavech N., et al. Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies. J Urol. 146:1991;1034-1039.
8. Duchesne G.M., Peters L.J. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 44:1999;747-748.
9. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101.
10. Brenner D.J., Hall E.J. Letter. Low α/β values for prostate appear to be independent of modeling details. Int J Radiat Oncol Biol Phys. 47:2000;538-539.
11. Martinez A.A., Kestin L.L., Stromberg J.S., et al. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer The William Beaumont phase II dose-escalating trial . Int J Radiat Oncol Biol Phys. 47:2000;343-352.
12. Lloyd-Davies R.W., Collins C.D., Swan A.V. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962- 1984). Urology. 36:1990;107-111.